| Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles X Li, AM Aldayel, Z Cui Journal of controlled release 173, 148-157, 2014 | 194 | 2014 |
| Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate AM Aldayel, HL O'Mary, SA Valdes, X Li, SG Thakkar, BE Mustafa, Z Cui Journal of Controlled Release 283, 280-289, 2018 | 98 | 2018 |
| Biodistribution and in Vivo Activities of Tumor-Associated Macrophage-Targeting Nanoparticles Incorporated with Doxorubicin M Niu, YW Naguib, AM Aldayel, Y Shi, SD Hursting, MA Hersh, Z Cui Molecular Pharmaceutics 11 (12), 4425-4436, 2014 | 98 | 2014 |
| Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-α siRNA in chronic inflammation sites AM Aldayel, YW Naguib, HL O'mary, X Li, M Niu, TB Ruwona, Z Cui Molecular Therapy-Nucleic Acids 5, 2016 | 49 | 2016 |
| Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine SG Thakkar, ZN Warnken, RF Alzhrani, SA Valdes, AM Aldayel, H Xu, ... Journal of controlled release 292, 111-118, 2018 | 46 | 2018 |
| Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model HL O’Mary, AM Aldayel, SA Valdes, YW Naguib, X Li, K Salvady, Z Cui Molecular pharmaceutics 14 (6), 1929-1937, 2017 | 16 | 2017 |
| Synthesis, characterization, and in vitro and in vivo evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with potent and broad-spectrum antitumor activity YW Naguib, D Lansakara-P, LM Lashinger, BL Rodriguez, S Valdes, ... Neoplasia 18 (1), 33-48, 2016 | 15 | 2016 |
| Effect of the ratio of betamethasone to TNF-α siRNA Coencapsulated in solid lipid nanoparticles on the acute Proinflammatory activity of the nanoparticles HL O’Mary, MS Hanafy, AM Aldayel, SA Valdes, RF Alzhrani, S Hufnagel, ... Molecular pharmaceutics 16 (11), 4496-4506, 2019 | 10 | 2019 |
| O, Mary, HL; Valdes, SA; Li, X.; Thakkar, S. G.; Mustafa, BE; Cui, Z. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid … AM Aldayel J. Controlled Release 283, 280-289, 2018 | 5 | 2018 |
| Selectively cleavable therapeutic nanoparticles Z Cui, A Aldayel US Patent App. 17/311,159, 2021 | 3 | 2021 |
| Effect of nanoparticle size on their distribution and retention in chronic inflammation sites AM Aldayel, S Hufnagel, HL O’Mary, SA Valdes, RF Alzhrani, H Xu, Z Cui Discover Nano 18 (1), 105, 2023 | 1 | 2023 |
| Nanotechnology used for Hair Strength and Color AMA Majed Alfadhel | | 2023 |
| Discover Nano AM Aldayel, S Hufnagel, HL O’Mary, SA Valdes, RF Alzhrani, H Xu, Z Cui | | 2023 |
| Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents Z Cui, A Aldayel, OM Hannah US Patent 11,529,314, 2022 | | 2022 |
| Towards targeted delivery of biologics to chronic inflammation sites using innovative nanosystems AM Aldayel | | 2018 |
| 168. A Novel TNF-alpha siRNA Formulation for Potential Treatment of Chronic Inflammation AM Aldayel, M Niu, Z Cui Molecular Therapy 23, 1, 2015 | | 2015 |
| Efficient Targeting of Tumor-Associated Macrophages (TAMs) Using a Polymeric Nanoplatform Surface-Functionalized with Mannose and Acid-Sensitive Sheddable PEG M Niu, YW Naguib, AM Aldayel, Z Cui | | |
| Lipid bilayer permeation is considered the major route for in vivo barrier passage of drugs. Despite this fact, no technique is currently available to measure the kinetics of … X Li, AM Aldayel, Z Cui | | |
| Supporting information: Biodistribution and in vivo activities of tumor-associated macrophage-targeting M Niu, YW Naguib, AM Aldayel, Y Shi, SD Hursting, MA Hersh, Z Cui | | |
